Novavax, Inc. (NVAX)

Novavax Market Cap

Novavax has a market cap or net worth of $1.63 billion as of March 19, 2026. Its market cap has increased by 32.03% in one year.

• Market Cap: 1.63B
• Enterprise Value: 1.17B
• 1-Year Change: 32.03%
• Ranking: #2121
• Category: Small-Cap
• Stock Price: $10.01

Market Cap Chart

Since December 1, 1998, Novavax's market cap has increased from $25.70M to $1.63B, an increase of 6,246.26%. That is a compound annual growth rate of 16.41%.

Market Cap History

Date	Market Cap	% Change
Mar 18, 2026	1.63B	49.36%
Dec 31, 2025	1.09B	-15.21%
Dec 31, 2024	1.29B	125.87%
Dec 29, 2023	570.20M	-29.34%
Dec 30, 2022	807.00M	-92.54%
Dec 31, 2021	10.82B	52.38%
Dec 31, 2020	7.10B	6,609.55%
Dec 31, 2019	105.80M	-84.98%
Dec 31, 2018	704.40M	81.13%
Dec 29, 2017	388.90M	13.78%
Dec 30, 2016	341.80M	-84.90%
Dec 31, 2015	2.26B	60.10%
Dec 31, 2014	1.41B	32.47%
Dec 31, 2013	1.07B	281.83%
Dec 31, 2012	279.60M	92.96%
Dec 30, 2011	144.90M	-46.33%
Dec 31, 2010	270.00M	8.56%
Dec 31, 2009	248.70M	90.28%
Dec 31, 2008	130.70M	-36.71%
Dec 31, 2007	206.50M	-18.35%
Dec 29, 2006	252.90M	33.74%
Dec 30, 2005	189.10M	46.70%
Dec 31, 2004	128.90M	-28.82%
Dec 31, 2003	181.10M	182.53%
Dec 31, 2002	64.10M	-80.46%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Ocular Therapeutix	1.90B
Mesoblast	1.87B
Definium Therapeutics	1.84B
Relay Therapeutics	1.83B
Recursion Pharmaceuticals	1.82B
Zymeworks	1.79B
Sarepta Therapeutics	1.79B
Soleno Therapeutics	1.75B